Competitive PositionD&T performance was significantly lower than peer Siemens Healthineers, suggesting market share loss in value (-1% vs +8%).
Earnings Performance4Q 2024 came below expectations for Philips with 4Q sales -1% vs consensus, with an organic growth of +1.0% vs +1.7% expected.
Market Performance In ChinaChina had a double-digit decline this quarter, mainly impacting Personal Health and D&T, and visibility in China remains very low, leaving uncertainty about whether the slowdown is market-wide or specific to Philips.